Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Inflammation 2Frailty 2Uterine Cervical Dysplasia 1Squamous Intraepithelial Lesions 1Papillomavirus Infections 1Leiomyoma 1Atypical Squamous Cells of the Cervix 1

Interventions

Specimen Handling 6Human Papillomavirus DNA Tests 4Colposcopy 4Papillomavirus Vaccines 2Human Papillomavirus Recombinant Vaccine nonavalent 2Cisplatin 2Carboplatin 2toripalimab 1fludarabine phosphate 1fludarabine 1epigallocatechin gallate 1aldesleukin 1Transurethral Resection of Prostate 1Standing Orders 1Respiratory Function Tests 1Radiotherapy, Intensity-Modulated 1Radiosurgery 1Radiation 1Prochlorperazine 1Positron-Emission Tomography 1Platinum 1Ondansetron 1O(6)-codeine methyl ether 1Methods 1Meperidine 1Magnetic Resonance Imaging 1Loperamide 1Interleukin-2 1Innovar 1Indomethacin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Papillomavirus Infections × epigallocatechin gallate × 90 days × Clear all
NCT07572396 2026-05-14

Phase II Study of Dysplasixâ„¢ Intravaginal Suppositories in Patients Patients With High-Risk HPV and Mild Cervical Cytologic Abnormalities

Amplexd Therapeutics, Inc.

Phase 2 Recruiting
45 enrolled
Gynecologic

Squamous Intraepithelial Lesions, Uterine Cervical Dysplasia, Papillomavirus Infections, Atypical Squamous Cells of the Cervix

Data powered by HemOnc (CC BY 4.0) Colophon âš¡